BioNTech Announces Layoffs as Covid-19 Revenue Slides
BioNTech (BNTX) stock was under pressure on May 5 after the multinational announced plans to eliminate up to 1,860 roles as it continues to grapple with declining COVID-19 vaccine sales. The selloff saw BNTX slip below its 50-day moving average…














